Psychoactive drugs alter the brain by mimicking, amplifying, or blocking the chemical signals that neurons use to communicate with each other. Nearly every substance that changes how you think, feel, or perceive the world does so by interfering with neurotransmitters, the molecular messengers that carry information between nerve cells. The specifics differ wildly depending on the drug class, but a shared theme runs through almost all of them: the brain’s reward circuitry, anchored in a region called the nucleus accumbens, gets hijacked. What makes the story more interesting than that one-liner suggests is how each class of drug pulls off the hijack differently, what happens to the brain when the hijack becomes chronic, and why some brains are far more vulnerable than others.
Getting Past the Gate
Before a drug can do anything to your brain, it has to physically reach it. The brain is protected by the blood-brain barrier, a tightly sealed layer of cells lining its blood vessels that blocks most molecules from crossing. Psychoactive drugs tend to be lipid-soluble, meaning they dissolve in fats, which lets them slip through this fatty barrier relatively easily. The degree of fat-solubility, molecular size, and whether the molecule gets actively pumped back out all shape how quickly and intensely a drug reaches brain tissue.1PubMed. Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents Heroin, for example, was specifically designed (by acetylating morphine) to be more fat-soluble than its parent compound, which is part of why it hits the brain faster and harder. The brain also has active transport systems that shuttle certain molecules in or out, adding another layer of complexity to which substances make it through and at what speed.2PubMed Central. The penetration of therapeutics across the blood-brain barrier: Classic case studies and clinical implications
The Reward System and Why It Matters So Much
The brain region most central to how psychoactive drugs produce their effects is the mesolimbic dopamine pathway, which runs from the ventral tegmental area (a small cluster of cells deep in the brainstem) up to the nucleus accumbens. When something good happens, like eating a satisfying meal or receiving an unexpected compliment, dopamine flows along this pathway and produces a feeling of motivation and anticipation. Drugs of abuse flood this same circuit with dopamine, but in amounts and patterns the system was never built to handle.
For a long time, researchers assumed that dopamine release in this pathway simply equaled pleasure. The picture turned out to be more nuanced: dopamine spikes in response to unexpected or novel stimuli, whether they feel good or bad, and seems to signal “wanting” or expectation rather than pure enjoyment.3PubMed Central. Neurobiologic processes in drug reward and addiction That distinction matters because it helps explain why addiction involves compulsive drug-seeking long after the drug has stopped being particularly pleasurable. Chronic drug use progressively recruits other brain regions, embedding drug-associated cues into the amygdala (which processes emotional memory) and pulling in the prefrontal cortex, which handles judgment and decision-making.4PubMed Central. The Neuroscience of Drug Reward and Addiction The result is that the brain rewires itself so that drug cues trigger intense craving even when the person consciously wants to stop.
How Stimulants Reshape Dopamine Signaling
Cocaine, amphetamines, and methamphetamine all boost dopamine levels in the nucleus accumbens, but they do it through different mechanisms. Cocaine primarily blocks the dopamine transporter, a protein that normally sucks dopamine back into the sending neuron after it has done its job. By parking itself on the transporter, cocaine lets dopamine linger in the gap between neurons far longer than it should. Amphetamines go a step further: they not only block reuptake but also force the transporter to run in reverse, actively pumping extra dopamine out of the neuron and into the synapse.5PubMed Central. Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms
The flood of dopamine is what produces the rush, the euphoria, and the heightened energy. But with repeated use, the brain compensates by dialing down its sensitivity to dopamine, which means you need more of the drug to feel the same effect. Methamphetamine causes particularly severe downstream damage: beyond just altering dopamine function, chronic use leads to neuron death, brain inflammation, and disruption of serotonin signaling.6PubMed Central. Neurotoxicity of methamphetamine: Main effects and mechanisms
How Depressants Quiet the Brain
Alcohol, benzodiazepines, and barbiturates work on the opposite side of the equation. Instead of revving up excitatory signaling, they amplify the brain’s main inhibitory system: GABA. GABA is the neurotransmitter responsible for slowing neurons down and reducing their excitability. These drugs enhance GABA’s effects at its receptors, causing neurons to fire less, which produces sedation, anxiety relief, and at higher doses, loss of coordination and consciousness.7PubMed Central. The role of GABAA receptors in mediating the effects of alcohol in the central nervous system
Alcohol in particular has a double-barreled effect: it boosts GABA signaling while simultaneously damping down glutamate, the brain’s primary excitatory neurotransmitter. Ethanol inhibits a specific glutamate receptor both directly and indirectly through its effects on GABA, and this combined suppression of excitatory activity is enough to completely block long-term potentiation, the cellular process underlying learning and memory formation.8PubMed. Evidence for a role for GABA(A) and NMDA receptors in ethanol inhibition of long-term potentiation That is why blackouts happen: the brain literally cannot form new memories while saturated with alcohol.
Opioids and the Pain-Pleasure Axis
Opioids like morphine, heroin, fentanyl, and prescription painkillers work by binding to mu-opioid receptors, which are naturally activated by the brain’s own pain-relieving chemicals (endorphins). When an opioid locks onto these receptors, it suppresses pain signaling, produces a warm euphoria, and triggers dopamine release in the reward pathway. The system the brain uses for stress and pain management, which normally involves careful balance between reward and aversion signals, gets overwhelmed.
The kappa opioid receptor system plays an interesting counterbalancing role here. Normally, kappa receptors respond to a chemical called dynorphin and create feelings of discomfort and aversion, acting as a brake on the reward system by inhibiting dopamine release. Chronic opioid use disrupts this balance, contributing to the deeply unpleasant emotional state that drives compulsive drug-seeking.9PubMed Central. KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway
Opioids also carry the distinct danger of suppressing breathing. Mu-opioid receptors sit in brainstem areas that control the rhythm of respiration, and activating them can slow or stop the automatic drive to breathe, which is how overdose deaths occur.10PubMed. Mechanisms of opioid-induced respiratory depression
Psychedelics and the Dissolving Default Mode
Classic psychedelics like psilocybin, LSD, and DMT act primarily on serotonin 2A receptors. When these receptors get activated on specific neurons deep in the cortex, they trigger a cascade that increases glutamate release in an unusually disorganized way. The result is a kind of neural chaos: brain regions that normally fire in synchronized, predictable patterns start behaving more randomly. Researchers describe this as increased “brain entropy,” meaning more unpredictability and less top-down control over cognition.11PubMed Central. Default Mode Network Modulation by Psychedelics: A Systematic Review
One of the most affected networks is the default mode network, a set of interconnected brain regions most active during self-referential thinking, mind-wandering, and maintaining your sense of personal identity. Psychedelics reduce the coordinated activity of this network, which may be why people under their influence report ego dissolution, a feeling that the boundaries of the self have melted away. This disruption is temporary, but there is growing interest in whether it may also be therapeutically useful, since the default mode network appears overactive in conditions like depression and addiction.
Cannabinoids Run the Signal Backwards
Cannabis works through a mechanism unlike any other major drug class. The brain has its own endocannabinoid system: when a neuron fires, it can release naturally produced cannabinoid molecules that travel backward across the synapse to the sending neuron, where they activate CB1 receptors and tell it to quiet down.12PubMed. Endocannabinoid signaling in the brain THC, the main psychoactive compound in cannabis, mimics these endocannabinoids by binding to the same CB1 receptors. Because this retrograde signaling system touches almost every major neurotransmitter pathway, the effects of THC are remarkably diverse: altered time perception, relaxation, heightened sensory experience, anxiety, impaired short-term memory, and increased appetite can all occur from the same compound in the same session.13PubMed. Retrograde signalling by endocannabinoids
The breadth of effects comes from where CB1 receptors sit. They are dense in the hippocampus (memory), cerebellum (motor coordination), prefrontal cortex (judgment), and amygdala (emotion). THC dials down neurotransmitter release at all of these sites simultaneously.
Dissociatives and the NMDA Block
Ketamine, PCP, and nitrous oxide belong to a class called dissociatives, named for the feeling of detachment from the body and surroundings they produce. The primary target for ketamine and PCP is the NMDA receptor, a glutamate receptor crucial for excitatory signaling and synaptic plasticity. By blocking NMDA receptors, these drugs disrupt the normal flow of excitatory communication. Paradoxically, blocking these receptors on certain inhibitory neurons actually disinhibits the broader circuit, leading to a surge of glutamate elsewhere in the cortex.14PubMed Central. Ketamine and the Disinhibition Hypothesis: Neurotrophic Factor-Mediated Treatment of Depression
This disinhibition also generates distinctive patterns of brain oscillations. At low doses, ketamine produces fast gamma-frequency oscillations associated with the “dissociative high.” At higher doses, it produces slow delta oscillations more consistent with sedation and anesthesia.15PubMed Central. Ketamine can produce oscillatory dynamics by engaging mechanisms dependent on the kinetics of NMDA receptors The same NMDA-blocking mechanism is also what makes ketamine a fast-acting antidepressant, a therapeutic angle discussed further below.
Why Tolerance Develops
Use any psychoactive drug repeatedly and the brain pushes back. The general principle is straightforward: when a drug artificially boosts a signal, the brain compensates by weakening the system that receives it. With opioids, this involves the mu-opioid receptor itself being chemically modified (phosphorylated), uncoupled from its internal signaling partners, and pulled off the cell surface through a process called internalization.16PubMed Central. Opioid receptor desensitization: mechanisms and its link to tolerance
Morphine presents a strange case that has taught researchers a lot about tolerance. Unlike most opioids, morphine does not trigger robust receptor internalization. You might expect that to prevent tolerance, but the opposite happens: because the receptors stay on the surface and keep signaling for abnormally long periods, the cell adapts by ramping up opposing pathways. Mutations that force the receptor to internalize normally actually reduce tolerance development.17PubMed. Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal In other words, the brain’s attempt to recycle the receptor is protective, and morphine’s failure to trigger that recycling is part of why it leads to escalating doses.
What Happens During Withdrawal
If tolerance is the brain fighting the drug while it is present, withdrawal is what happens when the drug leaves and all those countermeasures are still running. A key player in opioid withdrawal is the locus coeruleus, a small brainstem nucleus packed with norepinephrine-producing neurons. During chronic opioid use, these neurons are suppressed. When the opioid is removed, they rebound dramatically, firing at more than double their normal rate.18PubMed. Local opiate withdrawal in locus coeruleus neurons in vitro That hyperactivity drives many of the classic withdrawal symptoms: anxiety, sweating, racing heart, muscle cramps, and insomnia.19PubMed. Afferent effects on locus coeruleus in opiate withdrawal
Alcohol withdrawal follows similar logic in reverse. Chronic drinking suppresses excitatory signaling and enhances inhibitory signaling. Remove the alcohol and the excitatory system rebounds without the brake, which is why severe alcohol withdrawal can cause seizures, a potentially fatal outcome that distinguishes it from most other drug withdrawals.
Physical Rewiring From Chronic Use
Beyond chemical changes, psychoactive drugs physically reshape the brain’s architecture at the level of individual synapses. In animal studies, cocaine self-administration increased the branching of dendrites (the receiving branches of neurons) and the density of dendritic spines (the tiny protrusions where synapses form) in both the nucleus accumbens and the prefrontal cortex. The incidence of branched spines, an unusual type rarely seen in normal tissue, increased roughly two-and-a-half-fold.20Synapse. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex Amphetamine produces strikingly similar changes: more branching, more spines, and a doubling of branched spines in the same regions.21PubMed. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine
Opioids, cannabinoids, and alcohol push the synaptic architecture in the opposite direction: withdrawal from these substances reduces the number of dendritic spines in the nucleus accumbens, specifically on the second-order branches where dopamine-releasing terminals make contact. Longer, thinner spines, thought to be important for learning, seem to be preferentially lost.22PubMed Central. The “addicted” spine The upshot is that stimulants produce excess, disordered connectivity, while depressants and opioids erode the connectivity that was there, and both patterns interfere with normal learning and decision-making.
Alcohol’s Extra Route to Brain Damage
Heavy, chronic alcohol use damages the brain through an additional pathway that has nothing to do with neurotransmitter disruption: thiamine deficiency. Alcohol interferes with the absorption and use of thiamine (vitamin B1), a molecule required by enzymes that keep brain cells supplied with energy. Without adequate thiamine, cells in vulnerable brain regions, especially the thalamus, begin to die.23PubMed Central. The role of thiamine deficiency in alcoholic brain disease The resulting condition, Wernicke-Korsakoff syndrome, causes confusion, coordination problems, and severe memory loss that can be permanent.
Animal studies show that thiamine deficiency unleashes a wave of neuroinflammation, with some inflammatory markers spiking as much as 26-fold in the thalamus.24PubMed Central. A Pivotal Role for Thiamine Deficiency in the Expression of Neuroinflammation Markers in Models of Alcohol-Related Brain Damage Chronic alcohol exposure by itself triggered comparatively minor immune changes; it was the thiamine depletion that drove the severe brain inflammation.25PubMed Central. Thiamine Deficiency and Neuroinflammation Are Important Contributors to Alcohol Use Disorder This is one reason heavy drinkers are routinely given thiamine supplements in emergency settings: the vitamin cannot undo existing damage, but it can slow or prevent further destruction.
When Drugs Are Combined
Most real-world drug use involves more than one substance, and the brain effects of combinations are not simply additive. In a rat study measuring real-time dopamine release, combining nicotine and caffeine produced a synergistic effect in the nucleus accumbens and striatum, meaning the dopamine surge was greater than what you would expect from adding the two individual effects together. Adding alcohol to the mix produced a synergistic dopamine response in the prefrontal cortex.26PubMed Central. Possible Potentiating Effects of Combined Administration of Alcohol, Caffeine, and Nicotine on In Vivo Dopamine Release in Addiction-Related Circuits Within the CNS of Rats
The combination of alcohol and cannabis carries its own synergistic risks. In mice, THC and ethanol together caused greater motor impairment than either substance alone. The mechanism involved THC activating CB1 receptors to suppress excitatory input to cerebellar Purkinje cells while ethanol simultaneously boosted inhibitory chloride currents in the same cells, essentially hitting the same neurons with a one-two punch from different directions.27Nature Metabolism. Combined alcohol and cannabinoid exposure leads to synergistic toxicity by affecting cerebellar Purkinje cells These findings help explain why driving under the influence of both substances is far more dangerous than either alone.
Why Adolescent Brains Are Especially Vulnerable
The adolescent brain is not a smaller version of the adult brain; it is a brain undergoing massive remodeling. Regions involved in reward and emotion mature earlier, while the prefrontal cortex, which provides impulse control and long-range planning, does not fully mature until the mid-twenties. Substance use during this window appears to disrupt normal developmental trajectories. Emerging research suggests that the extensive neuromaturational processes occurring during adolescence make the teenage brain more susceptible to the addictive properties of drugs, although there is also evidence that young people who start using substances early may have had pre-existing neurobiological vulnerabilities.28Sage Journals / Journal of Psychopharmacology. Substance use and the adolescent brain: a toxic combination? Disentangling cause and effect, whether the brain differences drove the drug use or the drug use caused the brain differences, remains one of the harder puzzles in the field.
Genetic Variation Shapes Individual Responses
Two people can take the same drug at the same dose and have starkly different brain responses. Part of this comes down to genetics. One of the clearest examples involves nicotine: genetic variants in both nicotinic acetylcholine receptors and the CYP2A6 enzyme, which handles about 70 percent of nicotine’s initial breakdown in the body, influence how many cigarettes a person smokes per day and how likely they are to become dependent.29PubMed Central. Genetic Vulnerability and Susceptibility to Substance Dependence Someone who metabolizes nicotine slowly gets a longer effect from each cigarette and may smoke fewer of them; someone who metabolizes it quickly may smoke more to maintain the same brain levels. Similar genetic variation affects the receptors and metabolizing enzymes for alcohol, opioids, and other substances.
The Gut’s Surprising Influence
An unexpected avenue of research has connected the gut microbiome to how the brain processes drugs. In male mice depleted of gut bacteria, nicotine produced stronger activation of the mesolimbic dopamine system and altered the rewarding and aversive effects of the drug in measurable ways. Mice without normal gut flora also had increased numbers of astrocytes (a type of brain support cell) in a specific sub-region of the ventral tegmental area, and their microglial populations, the brain’s resident immune cells, were reorganized.30PubMed Central. Impact of the gut microbiome on nicotine’s motivational effects and glial cells in the ventral tegmental area in male mice This research is still early, but it raises the possibility that differences in gut bacteria could help explain why some individuals find certain drugs more rewarding than others.
Therapeutic Uses of Brain-Altering Drugs
The same mechanisms that make psychoactive drugs dangerous also make some of them medically valuable under controlled conditions. Ketamine’s NMDA-blocking action, the same effect that produces dissociation at recreational doses, triggers a burst of brain-derived neurotrophic factor (BDNF) in the prefrontal cortex and hippocampus. BDNF promotes the growth and strengthening of synapses, and in rodent studies, ketamine rapidly increased the number and function of spine synapses in the prefrontal cortex and boosted neuron growth in the hippocampus.31PubMed Central. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine Esketamine, a derivative, is now approved for treatment-resistant depression, and its antidepressant effects appear within hours rather than the weeks required by traditional antidepressants.32PubMed Central. Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review The working theory is that NMDA blockade at rest deactivates a specific kinase, which releases a brake on local protein production, allowing BDNF to be synthesized and drive rapid synaptic repair.33PubMed. Synaptic mechanisms underlying rapid antidepressant action of ketamine
Psychedelics are being explored along similar lines. One hypothesis proposes that substances like psilocybin may temporarily reopen windows of neuroplasticity that normally close after childhood development, essentially putting the brain into a more flexible, learning-ready state.34PubMed Central. Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy If this idea holds up, it could explain why psychedelic-assisted psychotherapy seems to produce durable changes in conditions like PTSD and addiction after just a few sessions: the drug may be creating a biological window during which the brain is unusually receptive to new patterns of thought.
Why Plants Evolved These Chemicals in the First Place
There is something curious about the fact that so many plants produce chemicals that happen to fit human brain receptors. These compounds did not evolve for our benefit. Psychoactive plant chemicals are thought to have evolved as defensive compounds to deter herbivores or attract pollinators. A phylogenetic analysis of psychoactive plant use across cultures found that pharmacological traits related to hallucinogenic and sedative potential are conserved within plant families, and that unrelated plant families producing similar psychoactive effects tend to converge on the same neurotransmitter systems.35PubMed Central. The ethnobotany of psychoactive plant use: a phylogenetic perspective Nicotine is an insecticide. Caffeine disrupts insect nervous systems. Psilocybin may deter fungus-grazing animals. The fact that these molecules also happen to bind to receptors in the human brain is, from the plant’s perspective, an accident. From our perspective, it is the entire story.